The Scientist

» vision, disease/medicine and culture

Most Recent

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Book Excerpt from <em>Wondrous Truths</em>

Book Excerpt from Wondrous Truths

By | June 1, 2016

In Chapter 2 author J.D. Trout highlights the dividing line between truth and scientific “fact.”

0 Comments

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Hot Off the Presses

Hot Off the Presses

By | June 1, 2016

Beyond Biocentrism, The Sting of the Wild, The Birth of Anthropocene, and Ordinarily Well

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Scientific progress is only achieved when humans' innate sense of understanding is validated by objective reality.

6 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

2 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Genetic Connections Among Human Traits

Genetic Connections Among Human Traits

By | May 16, 2016

A study identifies genetic variants that are linked to multiple phenotypes.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech